Shopping Cart 0
Cart Subtotal
USD 0

Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Lonza Group Ltd (LONN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lonza Group Ltd (Lonza) is a provider of contract manufacturing and development solutions to life-science industry. The company offers services including, commercial mammalian and microbial manufacturing, clinical development and manufacturing. It also offers high potential active pharmaceutical ingredients, cell and gene therapy capabilities, advanced intermediates, oral drug product development services, cell-culture modeling, genome editing, endotoxin products, and research media and testing products. Lonza provides solutions for health and well-being, microbial and hygiene control, and composites and material protection. Lonza serves biotechnology, pharmaceutical, academic, and government research industries; manufacturers of health and consumer products; formulators and service companies. The company operates manufacturing and R&D facilities across Asia, Europe and Americas. Lonza is headquartered in Basel, Switzerland.

Lonza Group Ltd Key Recent Developments

Feb 13,2019: Emerald Health Pharmaceuticals and Lonza announce agreement for manufacturing of novel cannabinoid-derived drug candidate

Feb 11,2019: Lonza's new pooled donor suspension hepatocytes enable the next level of reliability, robustness and customizability

Jan 31,2019: Lonza CEO Richard Ridlinger to Step Down This Year

Jan 30,2019: Lonza achieved another excellent full-year result in 2018 with 9% organic sales growth and strong profitability driven by healthcare businesses

Jan 30,2019: Lonza announces succession of CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Lonza Group Ltd-Key Facts

Lonza Group Ltd-Key Employees

Lonza Group Ltd-Key Employee Biographies

Lonza Group Ltd-Key Operational Employees

Lonza Group Ltd-Major Products and Services

Lonza Group Ltd-History

Lonza Group Ltd-Company Statement

Lonza Group Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Lonza Group Ltd-Business Description

Business Segment: Pharma & Biotech

Overview

Performance

Business Segment: Specialty Ingredients

Overview

Performance

R&D Overview

Lonza Group Ltd-Corporate Strategy

Lonza Group Ltd-SWOT Analysis

SWOT Analysis-Overview

Lonza Group Ltd-Strengths

Lonza Group Ltd-Weaknesses

Lonza Group Ltd-Opportunities

Lonza Group Ltd-Threats

Lonza Group Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Lonza Group Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 13, 2019: Emerald Health Pharmaceuticals and Lonza announce agreement for manufacturing of novel cannabinoid-derived drug candidate

Feb 11, 2019: Lonza's new pooled donor suspension hepatocytes enable the next level of reliability, robustness and customizability

Jan 30, 2019: Lonza achieved another excellent full-year result in 2018 with 9% organic sales growth and strong profitability driven by healthcare businesses

Jan 30, 2019: Lonza announces succession of CEO

Jan 15, 2019: Lonza announces retirement of Fridtjof Helemann

Jan 08, 2019: The world's first fully automated plate-based robotic solution for high precision in endotoxin detection

Dec 10, 2018: Lonza to establish Strategic Biomanufacturing base in China using GE Healthcare Solution

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Lonza Group Ltd, Performance Chart (2014-2018)

Lonza Group Ltd, Ratio Charts

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Lonza Group Ltd, Key Facts

Lonza Group Ltd, Key Employees

Lonza Group Ltd, Key Employee Biographies

Lonza Group Ltd, Key Operational Employees

Lonza Group Ltd, Major Products and Services

Lonza Group Ltd, History

Lonza Group Ltd, Subsidiaries

Lonza Group Ltd, Joint Venture

Lonza Group Ltd, Key Competitors

Lonza Group Ltd, Annual Ratios

Lonza Group Ltd, Annual Ratios (Cont...1)

Lonza Group Ltd, Annual Ratios (Cont...2)

Lonza Group Ltd, Interim Ratios

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Lonza Group Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Lonza Group Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Zep Inc.

Sannitree International

Royal DSM NV

NBE-Therapeutics AG

Mabuhay Vinyl Corp

Dottikon ES Holding AG

Caladrius Biosciences Inc

BASF SE

Aliancys AG

Actelion Pharmaceuticals Ltd

Company Profile

Company Profile Title

Lonza Group Ltd (LONN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lonza Group Ltd (Lonza) is a provider of contract manufacturing and development solutions to life-science industry. The company offers services including, commercial mammalian and microbial manufacturing, clinical development and manufacturing. It also offers high potential active pharmaceutical ingredients, cell and gene therapy capabilities, advanced intermediates, oral drug product development services, cell-culture modeling, genome editing, endotoxin products, and research media and testing products. Lonza provides solutions for health and well-being, microbial and hygiene control, and composites and material protection. Lonza serves biotechnology, pharmaceutical, academic, and government research industries; manufacturers of health and consumer products; formulators and service companies. The company operates manufacturing and R&D facilities across Asia, Europe and Americas. Lonza is headquartered in Basel, Switzerland.

Lonza Group Ltd Key Recent Developments

Feb 13,2019: Emerald Health Pharmaceuticals and Lonza announce agreement for manufacturing of novel cannabinoid-derived drug candidate

Feb 11,2019: Lonza's new pooled donor suspension hepatocytes enable the next level of reliability, robustness and customizability

Jan 31,2019: Lonza CEO Richard Ridlinger to Step Down This Year

Jan 30,2019: Lonza achieved another excellent full-year result in 2018 with 9% organic sales growth and strong profitability driven by healthcare businesses

Jan 30,2019: Lonza announces succession of CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Lonza Group Ltd-Key Facts

Lonza Group Ltd-Key Employees

Lonza Group Ltd-Key Employee Biographies

Lonza Group Ltd-Key Operational Employees

Lonza Group Ltd-Major Products and Services

Lonza Group Ltd-History

Lonza Group Ltd-Company Statement

Lonza Group Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Lonza Group Ltd-Business Description

Business Segment: Pharma & Biotech

Overview

Performance

Business Segment: Specialty Ingredients

Overview

Performance

R&D Overview

Lonza Group Ltd-Corporate Strategy

Lonza Group Ltd-SWOT Analysis

SWOT Analysis-Overview

Lonza Group Ltd-Strengths

Lonza Group Ltd-Weaknesses

Lonza Group Ltd-Opportunities

Lonza Group Ltd-Threats

Lonza Group Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Lonza Group Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 13, 2019: Emerald Health Pharmaceuticals and Lonza announce agreement for manufacturing of novel cannabinoid-derived drug candidate

Feb 11, 2019: Lonza's new pooled donor suspension hepatocytes enable the next level of reliability, robustness and customizability

Jan 30, 2019: Lonza achieved another excellent full-year result in 2018 with 9% organic sales growth and strong profitability driven by healthcare businesses

Jan 30, 2019: Lonza announces succession of CEO

Jan 15, 2019: Lonza announces retirement of Fridtjof Helemann

Jan 08, 2019: The world's first fully automated plate-based robotic solution for high precision in endotoxin detection

Dec 10, 2018: Lonza to establish Strategic Biomanufacturing base in China using GE Healthcare Solution

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Lonza Group Ltd, Performance Chart (2014-2018)

Lonza Group Ltd, Ratio Charts

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Lonza Group Ltd, Key Facts

Lonza Group Ltd, Key Employees

Lonza Group Ltd, Key Employee Biographies

Lonza Group Ltd, Key Operational Employees

Lonza Group Ltd, Major Products and Services

Lonza Group Ltd, History

Lonza Group Ltd, Subsidiaries

Lonza Group Ltd, Joint Venture

Lonza Group Ltd, Key Competitors

Lonza Group Ltd, Annual Ratios

Lonza Group Ltd, Annual Ratios (Cont...1)

Lonza Group Ltd, Annual Ratios (Cont...2)

Lonza Group Ltd, Interim Ratios

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Lonza Group Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Lonza Group Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Zep Inc.

Sannitree International

Royal DSM NV

NBE-Therapeutics AG

Mabuhay Vinyl Corp

Dottikon ES Holding AG

Caladrius Biosciences Inc

BASF SE

Aliancys AG

Actelion Pharmaceuticals Ltd